Heron Therapeutics Inc (HRTX)
3.005
+0.14
(+4.70%)
USD |
NASDAQ |
May 08, 13:47
Heron Therapeutics Cash from Operations (Quarterly): 2.455M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.455M |
| September 30, 2023 | -9.179M |
| June 30, 2023 | -27.16M |
| March 31, 2023 | -24.90M |
| December 31, 2022 | -37.53M |
| September 30, 2022 | -37.07M |
| June 30, 2022 | -28.37M |
| March 31, 2022 | -43.94M |
| December 31, 2021 | -45.26M |
| September 30, 2021 | -53.17M |
| June 30, 2021 | -62.99M |
| March 31, 2021 | -41.94M |
| December 31, 2020 | -52.55M |
| September 30, 2020 | -42.05M |
| June 30, 2020 | -57.28M |
| March 31, 2020 | -32.94M |
| December 31, 2019 | -26.98M |
| September 30, 2019 | -25.47M |
| June 30, 2019 | -23.11M |
| March 31, 2019 | -49.02M |
| December 31, 2018 | -33.49M |
| September 30, 2018 | -35.88M |
| June 30, 2018 | -60.73M |
| March 31, 2018 | -61.71M |
| December 31, 2017 | -47.15M |
| Date | Value |
|---|---|
| September 30, 2017 | -40.54M |
| June 30, 2017 | -32.03M |
| March 31, 2017 | -50.58M |
| December 31, 2016 | -38.52M |
| September 30, 2016 | -36.12M |
| June 30, 2016 | -27.11M |
| March 31, 2016 | -32.35M |
| December 31, 2015 | -23.15M |
| September 30, 2015 | -19.89M |
| June 30, 2015 | -15.82M |
| March 31, 2015 | -19.67M |
| December 31, 2014 | -12.86M |
| September 30, 2014 | -19.24M |
| June 30, 2014 | -12.48M |
| March 31, 2014 | -15.71M |
| December 31, 2013 | -9.627M |
| September 30, 2013 | -12.35M |
| June 30, 2013 | -10.82M |
| March 31, 2013 | -7.961M |
| December 31, 2012 | -6.125M |
| September 30, 2012 | -2.806M |
| June 30, 2012 | -3.971M |
| March 31, 2012 | -4.107M |
| December 31, 2011 | -2.475M |
| September 30, 2011 | -2.658M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-62.99M
Minimum
Jun 2021
2.455M
Maximum
Dec 2023
-35.23M
Average
-37.07M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| United Therapeutics Corp | 376.50M |
| Esperion Therapeutics Inc | -37.06M |
| Aldeyra Therapeutics Inc | -9.973M |
| Ocular Therapeutix Inc | -22.45M |
| Alpine Immune Sciences Inc | -18.97M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -8.836M |
| Cash from Financing (Quarterly) | 0.199M |
| Free Cash Flow | -60.33M |
| Free Cash Flow Per Share (Quarterly) | 0.0146 |
| Free Cash Flow to Equity (Quarterly) | 1.914M |
| Free Cash Flow Yield | -15.00% |